Scientific Research Facilities
The Department’s world-leading scientific research and specialist facilities provide essential support, expertise and knowledge to our research programmes. They afford the added value of partnership and expert advice in developing experiments, designing equipment, maintaining cutting edge technology and providing clinical support. We have invested heavily in these facilities to underpin the expanding Department and plug the gaps in support for our key areas of focus in cancer research. We also have strong links with other parts of the University and also tap into local expertise in neighbouring University facilities such as the Target Discovery Institute.
Supporting academic research within and outside of the university, we provide specialist analytical chemistry support in the majority through HPLC-MS or HPLC-MS-MS techniques with additional UV-visible absorbance and fluorescence detection abilities.
We provide expertise in computational biology ranging from applied statistics to computational and functional genomics.
The Early Phase Clinical Trials Unit (EPCTU) aims to support the translation of research findings in to clinical practice.
Flow cytometry determines the 'what', the 'where' and the 'how much' of material in cells, and is an important step in testing effects of drug interventions.
The Live Tissue Facility is designed to boost the translational impact of oncological research without users having to independently create ethics applications and collection logistics.
The Mechanical Workshop delivers an on-site fabrication facility for custom-made, precision mechanical items for use in scientific research.
The Microscopy SRF aims to provide research groups with imaging technologies to investigate cellular processes both in vitro and in vivo.
The Oncology Clinical Trials Office (OCTO) provides clinical trial management support to investigators across the CRUK Oxford Centre to manage trials from concept to completion.
The PET Radiochemistry and Radiopharmacy core supports radiochemistry-dependent research programmes and provide GMP-grade PET radiopharmaceuticals for clinical trials.
State-of-the art-imaging research and service platforms for in vivo study of disease models.
Proteomics studies proteins on a large scale. Proteins are vital to living organisms and their multi-functional characteristics act as potential targets for drug therapies. Therefore, proteomics can be used for biomarker and target discovery, drug profiling and target validation.
The Radiation Biophysics Facility develops and supports a unique range of radiation resources and techniques along with providing associated expertise.